Results 131 to 140 of about 2,176,861 (324)
Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres +4 more
wiley +1 more source
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials
Background Patient-focused approaches to capturing day-to-day variability in sleep disturbance are needed to properly evaluate the sleep benefits of new treatments.
Carla Dias-Barbosa +8 more
doaj +1 more source
Pruritus in chronic cholestatic liver diseases
Pruritus can be a prominent symptom in patients with chronic liver disorders, especially those with cholestasis, and substantially affects quality of life.
E. A. Orlova +6 more
core +1 more source
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva +17 more
wiley +1 more source
ABSTRACT Emollients and cleansers are essential components in managing atopic dermatitis (AD). While international evidence‐based guidelines recommend using gentle cleansers and emollients daily as a foundational therapy for AD, implementation in practice remains suboptimal.
Mette Deleuran +12 more
wiley +1 more source
Assessing Response to Difelikefalin in Adults Receiving Haemodialysis: A Multidisciplinary, Person‐Centred Framework for Chronic Kidney Disease‐Associated Pruritus [PDF]
Lucas Maciel de Almeida Corrêa +3 more
openalex +1 more source
Chronic pruritus may manifest itself clinically in terms of different duration, intensity and quality. There is no questionnaire assessing these parameters systematically.
Weisshaar, E;Stander, S;Gieler, U;Matterne, U;Darsow, U
core +1 more source
ABSTRACT Background Personalized treatment strategies for atopic dermatitis (AD) are limited. Although serum total IgE (tIgE) and blood eosinophil levels are proposed biomarkers for AD severity, their clinical utility requires validation. Objectives We aimed to identify biomarkers reflecting AD severity and their association with dupilumab efficacy ...
Zhuying Zhang, Jingwen Xue, Yi Zhao
wiley +1 more source

